Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukaemia

被引：0

作者：

Perz, JB ^{[1
]}

Sanz, J ^{[1
]}

Ghorashian, S ^{[1
]}

Chaidos, A ^{[1
]}

Kaeda, J ^{[1
]}

Szydlo, RM ^{[1
]}

Marin, DC ^{[1
]}

Olavarria, E ^{[1
]}

Apperley, JF ^{[1
]}

机构：

[1] Hammersmith Hosp, London, England

来源：

BONE MARROW TRANSPLANTATION | 2006年 / 37卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S227 / S227

页数：1

共 50 条

[31] Reduced-intensity allogeneic stem cell transplantation to complement therapy with imatinib for eradication of minimal residual disease in chronic myeloid leukaemia patients [J].

Copland, M ;

Heaney, N ;

Stewart, K ;

Godden, J ;

Smith, G ;

Crawley, C .

BONE MARROW TRANSPLANTATION, 2005, 35 :S206-S206

[32] Allogeneic stem cell transplantation for chronic myeloid leukemia [J].

Barrett, J .

SEMINARS IN HEMATOLOGY, 2003, 40 (01) :59-71

[33] Allogeneic stem cell transplantation in chronic myeloid leukaemia within the German Register of Stem Cell Transplantation (DRST) 1998-2004 [J].

Bacher, U. ;

Zabelina, T. ;

Ottinger, H. ;

Kroeger, N. ;

Zander, A. R. .

BONE MARROW TRANSPLANTATION, 2008, 41 :S304-S305

[34] Allogeneic stem cell transplantation with T cell depletion for acute myeloid leukaemia [J].

Thomson, KJ ;

Peggs, KS ;

Morris, EC ;

Khwaja, A ;

Linch, DC ;

Goldstone, AH ;

Mackinnon, S .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 :35-36

[35] Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia [J].

Kreuzer, KA ;

Schmidt, CA ;

Schetelig, J ;

Held, TK ;

Thiede, C ;

Ehninger, G ;

Siegert, W .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 69 (01) :7-10

[36] Allogeneic and autologous stem cell transplantation for chronic myelogenous leukaemia [J].

Mistrik, M ;

Hrubisko, M ;

Demeckova, E ;

Bojtarova, E ;

Kotoucek, P ;

Czako, B ;

Nachtmanova, K ;

Chabronova, J ;

Gubkova, M ;

Avramovova, M ;

Jankovicova, D ;

Martinka, J ;

Kusikova, M ;

Stemnicka, D ;

Batorova, A ;

Skrakova, M ;

Pavlikova, D ;

Cupanikova, D ;

Fehervizyova, E .

BONE MARROW TRANSPLANTATION, 2005, 35 :S381-S381

[37] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia [J].

A Bacigalupo .

Leukemia, 2003, 17 :1722-1722

[38] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia [J].

E Olavarria ;

O G Ottmann ;

M Deininger ;

R E Clark ;

G Bandini ;

J Byrne ;

J Lipton ;

A Vitek ;

M Michallet ;

W Siegert ;

A Ullmann ;

B Wassmann ;

D Niederwieser ;

T Fischer .

Leukemia, 2003, 17 :1707-1712

[39] Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia [J].

Luo, Yi ;

Zhao, Yanmin ;

Tan, Yamin ;

Shi, Jimin ;

Han, Xiaoyan ;

Zheng, Yanlong ;

Li, Li ;

He, Jingsong ;

Xie, Wanzhuo ;

Ye, Xiujin ;

Cai, Zhen ;

Lin, Maofang ;

Huang, He .

LEUKEMIA RESEARCH, 2011, 35 (10) :1307-1311

[40] COMPARISON OF ALLOGENEIC STEM CELL TRANSPLANTATION AND IMATINIB FOR CHRONIC MYELOID LEUKEMIA: RESULTS FROM CAMELIA REGISTRY [J].

Faber, E. ;

Muzik, J. ;

Koza, V. ;

Demeckova, E. ;

Voglova, J. ;

Demitrovicova, L. ;

Chudej, J. ;

Markuljak, I. ;

Cmunt, E. ;

Kozak, T. ;

Tothova, E. ;

Jarosova, M. ;

Dusek, L. ;

Indrak, K. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 :224-224

← 1 2 3 4 5 →